Search research articles
Contact Us
Filters
Showing results (131-140 of 336) with videos related to
Page
of 34
Sort By:
Leukemia & Lymphoma
|
April 15, 2014
Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia
Isabelle Herth, Manfred Hensel, Michael Rieger, et al.
Hemasphere
|
November 15, 2019
Maintenance Treatment for Patients With Mantle Cell Lymphoma: A Systematic Review and Meta-analysis of Randomized Trials
Liat Vidal, Anat Gafter-Gvili, Martin Dreyling, et al.
Hemasphere
|
July 11, 2022
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany
Daniela Skalt, Bernhard Moertl, Michael von Bergwelt-Baildon, et al.
Blood
|
March 18, 2025
Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation Status
Ciara L Freeman, Srimathi Srinivasan, Brendan Hodkinson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 18, 2011
Treatment of indolent lymphoma in Germany - results of a representative population-based survey
Christian Schmidt, Sebastian Fetscher, Christian Görg, et al.
Hematological Oncology
|
June 10, 2023
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus
Marie Moosburner, Lamija Alibegovic, Korbinian Hasselmann, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2021
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma
Matthew J Matasar, Martin Dreyling, Sirpa Leppä, et al.
Frontiers in Neurology
|
April 12, 2021
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma-Diagnostic, Therapeutic, and Prognostic Relevance
Ilias Masouris, Kirsi Manz, Markus Pfirrmann, et al.
British Journal of Haematology
|
July 16, 2010
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
Francesco d'Amore, John Radford, Thomas Relander, et al.
Leukemia & Lymphoma
|
August 5, 2011
Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia
Tobias Herold, Till Seiler, Rupert Egensperger, et al.
Page
of 34
Search research articles
Search
Showing results (131-140 of 336) with videos related to
Sort By:
Page
of 34
Leukemia & Lymphoma
|
April 15, 2014
Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia
Isabelle Herth, Manfred Hensel, Michael Rieger, et al.
Hemasphere
|
November 15, 2019
Maintenance Treatment for Patients With Mantle Cell Lymphoma: A Systematic Review and Meta-analysis of Randomized Trials
Liat Vidal, Anat Gafter-Gvili, Martin Dreyling, et al.
Hemasphere
|
July 11, 2022
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany
Daniela Skalt, Bernhard Moertl, Michael von Bergwelt-Baildon, et al.
Blood
|
March 18, 2025
Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation Status
Ciara L Freeman, Srimathi Srinivasan, Brendan Hodkinson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 18, 2011
Treatment of indolent lymphoma in Germany - results of a representative population-based survey
Christian Schmidt, Sebastian Fetscher, Christian Görg, et al.
Hematological Oncology
|
June 10, 2023
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus
Marie Moosburner, Lamija Alibegovic, Korbinian Hasselmann, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2021
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma
Matthew J Matasar, Martin Dreyling, Sirpa Leppä, et al.
Frontiers in Neurology
|
April 12, 2021
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma-Diagnostic, Therapeutic, and Prognostic Relevance
Ilias Masouris, Kirsi Manz, Markus Pfirrmann, et al.
British Journal of Haematology
|
July 16, 2010
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
Francesco d'Amore, John Radford, Thomas Relander, et al.
Leukemia & Lymphoma
|
August 5, 2011
Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia
Tobias Herold, Till Seiler, Rupert Egensperger, et al.
Page
of 34